Price T Rowe Associates Inc Legend Biotech Corp Call Options Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
231Shares Held
71.2MCall Options Held
191KPut Options Held
350K-
Westfield Capital Management CO LP Boston, MA6.92MShares$251 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$217 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$207 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$136 Million5.57% of portfolio
-
Braidwell LP Stamford, CT2.98MShares$108 Million6.2% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.07B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...